GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LAVA Therapeutics NV (NAS:LVTX) » Definitions » Net Margin %

LAVA Therapeutics NV (LAVA Therapeutics NV) Net Margin % : -1,840.79% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is LAVA Therapeutics NV Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. LAVA Therapeutics NV's Net Income for the three months ended in Dec. 2023 was $-6.50 Mil. LAVA Therapeutics NV's Revenue for the three months ended in Dec. 2023 was $0.35 Mil. Therefore, LAVA Therapeutics NV's net margin for the quarter that ended in Dec. 2023 was -1,840.79%.

The historical rank and industry rank for LAVA Therapeutics NV's Net Margin % or its related term are showing as below:

LVTX' s Net Margin % Range Over the Past 10 Years
Min: -791.68   Med: -522.58   Max: -164.55
Current: -620.09


LVTX's Net Margin % is ranked worse than
67.41% of 1028 companies
in the Biotechnology industry
Industry Median: -157.59 vs LVTX: -620.09

LAVA Therapeutics NV Net Margin % Historical Data

The historical data trend for LAVA Therapeutics NV's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LAVA Therapeutics NV Net Margin % Chart

LAVA Therapeutics NV Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
- -425.06 -791.68 -164.55 -620.09

LAVA Therapeutics NV Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -564.96 -1,138.89 -247.13 -16,671.70 -1,840.79

Competitive Comparison of LAVA Therapeutics NV's Net Margin %

For the Biotechnology subindustry, LAVA Therapeutics NV's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LAVA Therapeutics NV's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LAVA Therapeutics NV's Net Margin % distribution charts can be found below:

* The bar in red indicates where LAVA Therapeutics NV's Net Margin % falls into.



LAVA Therapeutics NV Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

LAVA Therapeutics NV's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-41.974/6.769
=-620.09 %

LAVA Therapeutics NV's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-6.498/0.353
=-1,840.79 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LAVA Therapeutics NV  (NAS:LVTX) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


LAVA Therapeutics NV Net Margin % Related Terms

Thank you for viewing the detailed overview of LAVA Therapeutics NV's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


LAVA Therapeutics NV (LAVA Therapeutics NV) Business Description

Traded in Other Exchanges
Address
Yalelaan 62, Utrecht, UT, NLD, 3584 CM
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells.

LAVA Therapeutics NV (LAVA Therapeutics NV) Headlines